Neoadjuvant chemotherapy for soft tissue sarcoma

被引：0

作者：

Wöll E. ^{[1
]}

机构：

[1] St. Vinzenz Hospital, Zams Sanatoriumstr. 43, Zams

来源：

memo - Magazine of European Medical Oncology | 2014年 / 7卷 / 3期

关键词：

Doxorubicin; Gemcitabibne; Ifosfamide; Neoadjuvant chemotherapy; Soft tissue sarcoma; Taxanes; Trabectedin;

D O I：

10.1007/s12254-014-0170-8

中图分类号：

学科分类号：

摘要：

Soft tissue sarcoma is a rare and very heterogeneous disease. The prognosis of these cancers is mainly influenced by histological grading size location and type of histology. Many aspects argue in favor of neoadjuvant chemotherapy but no singular trial could unambiguously prove an advantage of neoadjuvant therapy. This short review has a focus on neoadjuvant chemotherapy as induction therapy prior to chemoradiation or neoadjuvant chemotherapy alone. © 2014 Springer-Verlag Wien.

引用

页码：169 / 171

页数：2

共 50 条

[41] Randomized Clinical Trials in Soft Tissue Sarcoma
Katz, Steven C.
Brennan, Murray F.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (01) : 1 - +
[42] Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy
Charlson, John
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (12)
[43] The role of perioperative chemotherapy in primary high- grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARC
Acem, Ibtissam
van Houdt, Winan J.
Grunhagen, Dirk J.
van der Graaf, Winette T. A.
Rueten-Budde, Anja J.
Gelderblom, Hans
Verhoef, Cornelis
van de Sande, Michiel A. J.
EUROPEAN JOURNAL OF CANCER, 2022, 165 : 71 - 80
[44] Update on Dosing and Fractionation for Neoadjuvant Radiotherapy for Localized Soft Tissue Sarcoma
Roohani, Siyer
Wiltink, Lisette M.
Kaul, David
Spalek, Mateusz Jacek
Haas, Rick L.
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (04) : 543 - 555
[45] Update on Dosing and Fractionation for Neoadjuvant Radiotherapy for Localized Soft Tissue Sarcoma
Siyer Roohani
Lisette M. Wiltink
David Kaul
Mateusz Jacek Spałek
Rick L. Haas
Current Treatment Options in Oncology, 2024, 25 : 543 - 555
[46] Radiographic and Histologic Response to Neoadjuvant Radiotherapy in Patients With Soft Tissue Sarcoma
Robert J. Canter
Steve R. Martinez
Robert M. Tamurian
Maaya Wilton
Chin-Shang Li
Janice Ryu
Walter Mak
Wayne L. Monsky
Dariusz Borys
Annals of Surgical Oncology, 2010, 17 : 2578 - 2584
[47] Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities
Curtis, Kelly K.
Ashman, Jonathan B.
Beauchamp, Christopher P.
Schwartz, Adam J.
Callister, Matthew D.
Dueck, Amylou C.
Gunderson, Leonard L.
Fitch, Tom R.
RADIATION ONCOLOGY, 2011, 6
[48] Adaptive radiotherapy in patients receiving neoadjuvant radiation for soft tissue sarcoma
Abu-Hijlih, Ramiz
Mheid, Sara
Abuhijla, Fawzi
Asha, Wafa
Mohamad, Issa
Alrashdan, Abdullah
Alheet, Samer
Kana'an, Haitham
Abd Al-Raheem, Mohammad
Almousa, Abdelatif
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2019, 24 (03) : 263 - 268
[49] Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas
Loong, Herbert H.
Wong, Kwan-Hung
Tse, Teresa
ESMO OPEN, 2018, 3
[50] Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma A Report of Twenty-Eight Patients
Wang, Bing
Yu, Xiuchun
Xu, Songfeng
Xu, Ming
MEDICINE, 2016, 95 (04)

← 1 2 3 4 5 →